Qutenza® (capsaicin) 8% patch is indicated for the management of neuropathic pain associated with postherpetic neuralgia (PHN). PHN is also known as post-shingles nerve pain. Qutenza delivers medicine directly into the skin to the nerves that cause pain after shingles. A single, 1-hour application can provide up to three months of pain relief.
The active ingredient in Qutenza is a pharmaceutical grade, prescription-strength formulation of capsaicin. Qutenza is believed to provide pain reduction by acting on hyperactive pain nerves which have been damaged due to shingles.
Shingles is a disease caused by the same virus that causes chickenpox. In people with shingles, the chickenpox virus, which has been inactive in the body, returns and travels along the nerves in the skin, damaging the nerves and causing rash, blisters, and pain. In some people, this pain can continue for months or years after the shingles rash has healed.
The pain from damaged nerves may feel like a sharp, burning, tingling, shooting, or numb sensation. This pain can disrupt sleep, mood, work, and activities of daily living. The risk of developing PHN increases with age (especially in people over 60) and for patients who experienced severe pain or severe rash during the acute shingles episode.
Qutenza is applied by a doctor or healthcare professional directly to the skin at the painful site. It is the only pharmaceutical grade, prescription-strength capsaicin formulation currently available. It is non-narcotic and is unlikely to have drug-drug interaction. Qutenza can be used alone or in combination with other pain medications.
For more information, visit www.qutenza.com.
Treatment with Qutenza must be performed only by a healthcare provider. You should never apply or remove Qutenza yourself.
Warnings and Precautions:
These are not all the side effects of Qutenza. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch/, or call 1-800-FDA-1088.
For full Prescribing Information, please click here.
Qutenza® is a registered trademark of Acorda Therapeutics, Inc.